Skip to main content

Advertisement

SpringerLink
Log in

Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The present study was undertaken to investigate the expression of prostate-specific membrane antigen (PSMA) in normal breast tissues, in cancerous breast tissues and in distant metastases from patients with breast cancer. Immunohistochemical analysis was performed to determine PSMA expression and angiogenic activity using anti-PSMA mAb and anti-CD31 mAb respectively. Immunofluorescence staining was applied to confirm the exact co-localization of PSMA and CD31. We observed different patterns of PSMA expression between normal and cancerous tissues. Normal breast tissues showed PSMA expression only in normal glandular cells. However, primary breast tumors and distant metastases showed PSMA expression in tumor cells and in tumor-associated neovasculature. PSMA score group status in primary breast tumors was significantly associated with histologic type and tumor grade (p = 0.026 and p = 0.004 respectively). Distant metastases showed higher PSMA expression in tumor-associated neovasculature comparing with primary tumors. Moreover, brain tumor-associated neovasculture had significantly higher expression of PSMA comparing with bone tumor-associated neovasculture. The localized binding of PSMA mAb to the neovasculature endothelium was confirmed with the double Immunofluorescence staining. 68Ga-PSAM imaging of a patient with metastatic breast cancer showed strong tracer uptake in all known skeletal metastases. To the best of our knowledge, this study is the second one that has assessed PSMA expression in a large number of breast cancer patients. Our findings showed that PSMA is particularly expressed in tumor-associated neovasculature of breast tumors and its distant metastases, thus enhancing the evidence on the potential usefulness of PSMA as a therapeutic vascular target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Israeli RS, Powell CT, Fair WR, Heston WD (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227–230

    CAS  PubMed  Google Scholar 

  2. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C (1997) Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3:81–85

    CAS  PubMed  Google Scholar 

  3. Godron IO, Tretiakova MS, Noffsinger AE, Hart J, Reuter VE, Al-Ahmadie HA (2008) Prostate-specific membrane antigen expression in regeneration and repair. Mod Pathol 21:1421–1427

    Article  Google Scholar 

  4. Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Peter M, Rovito PM Jr, Wang CY, Haas GP (2006) Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg 30(4): 628–636

    Article  PubMed  Google Scholar 

  5. Rajasekaran AK, Anilkumar G, Christiansen JJ (2005) Is prostate-specific membrane antigene a multifunctional protein? Am J Physiol Cell Cell Physiol 288: C975–C981

    Article  CAS  Google Scholar 

  6. Shafizadeh TB, Halsted CH (2007) Gamma-glutamyl hydrolase, not glutamate carboxypeptidase II, hydrolyzes dietary folate in rat small intestine. J Nutr 137:1149–1153

    Article  CAS  PubMed  Google Scholar 

  7. Neale JH, Bzdega T, Wroblewska B (2000) N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75(2):443–452

    Article  CAS  PubMed  Google Scholar 

  8. Perner S, Hofer MD, Kim R, Shah RB, Li H, Möller P, Hautmann RE, Gschwend JE, Kuefer R, Rubin MA (2007) Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol 38:696–670

    Article  CAS  PubMed  Google Scholar 

  9. Ghosh A, Heston WD (2004) Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528–539

    Article  CAS  PubMed  Google Scholar 

  10. Nanus DM, Milowsky MI, Kostakoglu L, Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Bander NH (2003) Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol 170:S84–S88

    Article  PubMed  Google Scholar 

  11. Troyer JK, Beckett ML, Wright GL Jr (1995) Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 62:552–558

    Article  CAS  PubMed  Google Scholar 

  12. Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, Bander NH, Rajasekaran AK (2003) A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell 14:4835–4845

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L (2015) Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks. Eur J Nucl Med Mol Imaging 42:1971–1975

    Article  CAS  PubMed  Google Scholar 

  14. Osborna JR, Akhtar NH, Vallabhajosula S, Anand A, Deh K, Tagawa ST (2013) Prostate-specific membrane antigen-based imaging. Urol Oncol 31:144–154

    Article  Google Scholar 

  15. Jadvar H (2015) PSMA PET in prostate cancer. J Nucl Med 56:1131–1132

    Article  CAS  PubMed  Google Scholar 

  16. Ceci F, Uprimny C, Nilica B et al (2015) (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? Eur J Nucl Med Mol Imaging 42:1284–1294

    Article  PubMed  Google Scholar 

  17. Scott T, Tagawa MI, Milowsky M, Morris S, Vallabhajosula P, Christos NH, Akhtar et al (2013) Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res 19:5182–5191

    Article  Google Scholar 

  18. Weineisen M, Schottelius M, Simecek J et al (2015) 68Ga- and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies. J Nucl Med 56:1169–1176

    Article  CAS  PubMed  Google Scholar 

  19. Ren H, Zhang H, Wang X, Liu J, Yuan Z, Hao J (2014) Prostate-specific membrane antigen as a marker of pancreatic cancer cells. Med Oncol 31(3):857

    Article  PubMed  Google Scholar 

  20. Wang HL, Wang SS, Song WH, Pan Y, Yu HP, Si TG, Liu Y, Cui XN, Gue Z (2015) Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS ONE. https://doi.org/10.1371/journal.pone.0125924

    Google Scholar 

  21. Haffner MC, Kronberger IE, Ross JS et al (2009) Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol 40:1754–1761

    Article  CAS  PubMed  Google Scholar 

  22. Baccala A, Sercia L, Li J, Heston W, Zhou M (2007) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology 70:385–390

    Article  PubMed  Google Scholar 

  23. Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE (2011) Folate hydrolase (prostate-specific membrane antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod Pathol 24:1521–1529

    Article  CAS  PubMed  Google Scholar 

  24. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer inciedence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:359–386

    Article  Google Scholar 

  25. Wernicke AG, Varma S, Greenwood EA, Christos EA, Chao PJ, Liu KS, Bander H, Shin NH SJ (2013) Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. Acta Pathol Microbiol Immunol Scand (APMIS) 122:482–489

    Article  Google Scholar 

  26. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

    CAS  PubMed  Google Scholar 

  27. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1887

    Article  CAS  PubMed  Google Scholar 

  28. Ahmadzadehfar H, Zimbelmann S, Yordanova, A, Fimmers R, Kürpig S, Eppard E, Gaertner FC, Wei X, Hauser S, Essler M (2017) Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride. Oncotarget. https://doi.org/10.18632/oncotarget.15698

    Google Scholar 

  29. Uwe Haberkorn M, Eder K, Kopka JW, Babich, Eisenhut M (2017) New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-15-0820

    PubMed  Google Scholar 

  30. Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, Piccioni D, Juarez T, Pingle SC, Makale M, Kesari S (2014) Prostate specificmembraneantigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. https://doi.org/10.1186/1475-2867-14-26

    PubMed  PubMed Central  Google Scholar 

  31. Tykvart J, Navrátil V, Sedlák F, Corey E, Colombatti M, Fracasso G, Koukolík F, Bařinka C, Sácha P, Konvalinka J (2014) Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA). Prostate 74:1674–1690

    Article  CAS  PubMed  Google Scholar 

  32. Chang S, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB (1999) Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Prostate 59:3192–3198

    CAS  Google Scholar 

  33. Mhawech-Fauceglia P, Zhang S, Terracciano L, Terracciano L, Sauter G, Chadhuri A, Herrmann FR, Penetrante R (2007) Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique. Histopathology 50:472–483

    Article  CAS  PubMed  Google Scholar 

  34. Ross JS, Schenkein D, Webb I, Gray G, Deeds J, Meyer R, McDonald A, Sheehan C, Gray K (2004) Expression of prostate specific membrane antigen in the neo-vasculature of non-prostate cancers. J Clin Oncol 22(14-suppl):3110

    Article  Google Scholar 

  35. Bradbury R, Jiang WG, Cui YX (2016) MDM2 and PSMA play inhibitory roles in metastatic breast cancer cells through regulation of matrix metalloproteinases. Anticancer Res 36:1143–1152

    CAS  PubMed  Google Scholar 

  36. Liu T, Jabbes M, Nedrow-Byers JR, Wu LY, Bryan JN, Berkman CE (2011) Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium. Int J Oncol 38:1349–1355

    CAS  PubMed  Google Scholar 

  37. Nguyen DP, Xiong PL, Liu H, Pan S, Leconet W, Navarro V et al (2016) Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment. Mol Cancer Res 14:1045–1053

    Article  CAS  PubMed  Google Scholar 

  38. Al-Ahmadie HA, Olgac S, Gregor PD, Tickoo SK, Fine SW, Kondagunta GV, Scher HI, Morris MJ, Russo P, Motzer RJ, Reuter VE (2008) Expression of prostate-specific membrane antigen in renal cortical tumors. Mod Pathol 21:727–732

    Article  CAS  PubMed  Google Scholar 

  39. Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH (2006) Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol 26:5310–5324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Evans JC, Malhorta M, Cryan JF, OʹDriscoll CM (2016) The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. Br J Pharmacol 173:3041–3079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sathekge M, Modiselle M, Vorster M, Mokgoro N, Nyakale N, Mokaleng B, Ebenhan T (2015) 68Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging 42:1482–1483

    Article  PubMed  Google Scholar 

  42. Sathekge M, Lengana T, Modiselle M, Vorster M, Zeevaat JR, Maes A, Ebenhan T, Van de Wiele C (2017) 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. Eur J Nucl Med Mol Imaging 44:689–694

    Article  CAS  PubMed  Google Scholar 

  43. Von Hoff DD, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM et al (2016) Phase I study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors. Clin Cancer Res 22:3157–3163

    Article  Google Scholar 

  44. Milowsky MI, Nanus DM, Kostakoglu L, Sheehan CE, Vallabhajosula S, Goldsmith SJ, Ross JS, Bander NH (2007) Vascular targeted therapy with anti-prostate specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol 25:540–547

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Barbara Linxweiler from the department of obstetrics and gynecology, University Medical School of Saarland for her excellent technical assistance.

Author information

Authors and Affiliations

  1. Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, 66421, Homburg, Saar, Germany

    Mariz Kasoha, Clara Unger, Erich-Franz Solomayer & Ingolf Juhasz-Böss

  2. Institute of General and Surgical Pathology, University Medical School of Saarland, 66421, Homburg, Saar, Germany

    Rainer M. Bohle & Claudia Zaharia

  3. Department of Nuclear Medicine, Saarland University, 66421, Homburg, Saar, Germany

    Fadi Khreich

  4. Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, 66421, Homburg, Saar, Germany

    Stefan Wagenpfeil

Authors
  1. Mariz Kasoha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clara Unger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erich-Franz Solomayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rainer M. Bohle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudia Zaharia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fadi Khreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefan Wagenpfeil
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ingolf Juhasz-Böss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariz Kasoha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasoha, M., Unger, C., Solomayer, EF. et al. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases. Clin Exp Metastasis 34, 479–490 (2017). https://doi.org/10.1007/s10585-018-9878-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-018-9878-x

Keywords

Search

Navigation